Why Should You Attend:
Toxicology or non-clinical safety assessment is an important component of the overall drug development plans for new drug candidates and biologics. Often project teams struggle with issues of potential "toxicity" of their product candidate and are uncertain as to how to use the data to make good development decisions at the different stages of the drug development process.
Course participants will come away with practical knowledge of non-clinical safety assessment to improve their understanding and interpretation of toxicology data at all stages of drug development.Case studies will be used to highlight how acceptable safety margins for different therapeutic areas are calculated, and how these affect the interpretation of toxicology data. The course is designed for non-toxicologists who want to build their knowledge of drug safety assessment and improve their interactions with toxicologists on your project team.
Areas Covered in the seminar:
Who will benefit:This webinar will be valuable to all members of project development teams who want to develop a better understanding of drug safety assessment process and how the data should be used to make good development decisions. This course is designed for all those who come into contact with toxicology data, but who are not specialist toxicologists. No previous knowledge of toxicology is assumed. Participants who will benefit from this training include:
Paula J. Lapinskas, Ph.D. has a degree in molecular toxicology from Johns Hopkins university and has over 13 years industry experience in the pharmaceutical and biotech industry in the areas of regulatory and investigative toxicology with broad, leading edge experience in the development of drugs: from target validation to clinical development. Key successes in proactively identifying potential toxicity and other drug development issues (e.g. formulation, DMPK, ADME, etc.) and development of work plans to better assess potential risks and development huddles.
She has expertise in several therapeutic areas including: Immunology, Inflammation, oncology (multiple targets), Diabetes, CNS, Anti-infective, and signal transduction pathway modifiers. She is currently working as an independent toxicology consultant for both large and small pharmaceutical and biotech companies.
Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
PAYMENT METHOD: 100% Secure Transaction